Sanjiv Agarwala
Sanjiv Agarwala, MD, is the chief of medical oncology & hematology at St. Luke’s
Cancer Center and professor of medicine at Temple University School of Medicine, in
Philadelphia, Pennsylvania. Dr. Agarwala is nationally and internationally
recognized as an expert in the research and treatment of melanoma and
immunotherapy of cancer and has presented and led numerous conferences and
meetings across the globe.
Dr. Agarwala received his undergraduate education and medical degree from
Bombay University. He completed his medical training through residencies and
fellowships at the University of Bombay in India, Otago University in New Zealand,
and the University of Pittsburgh in Pennsylvania.
Dr. Agarwala has written and contributed to over 150 publications and book
chapters on melanoma and other research areas. He is board certified in oncology,
hematology, and internal medicine, as well as an active member of several
professional and scientific societies, such as the American Association for Cancer
Research, the American Society of Clinical Oncology, the European Society of
Medical Oncology, and the Society for Melanoma Research. Dr. Agarwala has been
the principal investigator for multiple clinical trials involving immunotherapy and
targeted therapy for melanoma and other malignancies, as he has special interest
and expertise in immunotherapy for cancer. As a result of his dedication to
melanoma and immunotherapy research, Dr. Agarwala has received several honors,
including listings as one of America’s top doctors for cancer and best doctors in the
United States.